Evidence map›Paper›PMID 37361347›Full record

ArticleEC psychology and psychiatry2023

Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) Behaviors.

Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, Debasis Bagchi, Eric R Braverman, Ashim Gupta, David Baron, Panayotis K Thanos, Jag Khalsa, Nicole Jafari and 8 more

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in EC psychology and psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 3 countries.

Kenneth BlumDivision of Addiction Research and Education, Center for Sports, Exercise and Global Mental Health, Western University of Health Sciences, Pomona, CA, USA.
Thomas McLaughlinDivision of Nutrigenomics, The Kenneth Blum Neurogenetic and Behavioral Institute, LLC., Austin, TX, USA.
Abdalla BowirratDepartment of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel.
Debasis BagchiDivision of Systems Biology, Victory Nutrition International (VNI), Bonita Springs, FL, USA.
Eric R BravermanDivision of Nutrigenomics, The Kenneth Blum Neurogenetic and Behavioral Institute, LLC., Austin, TX, USA.
Ashim GuptaFuture Biologics, Lawrenceville, GA, USA.
David BaronDivision of Addiction Research and Education, Center for Sports, Exercise and Global Mental Health, Western University of Health Sciences, Pomona, CA, USA.
Panayotis K ThanosBehavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Clinical Research Institute on Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, State University of New York at Buffalo, Buffalo, NY, USA.
Jag KhalsaDivision of Therapeutics and Medical Consequences, Medical Consequences of Drug Abuse and Infections Branch, National Institute on Drug Abuse, NIH, Special Volunteer, Gaithersburg, MD, USA.
Nicole JafariDepartment of Human Development, California State University at long Beach, Long Beach, CA, USA.
Foojan ZeineAwareness Integration Institute, San Clemente, CA, USA.
John GiordanoKetamine Infusion Clinic of South Florida, Pompano Beach, Fl, USA.
Catherine A DennenDepartment of Family Medicine, Jefferson Health Northeast, Philadelphia, PA, USA.
Margaret A MadiganDivision of Nutrigenomics, The Kenneth Blum Neurogenetic and Behavioral Institute, LLC., Austin, TX, USA.
Paul CarneyDivision Pediatric Neurology, University of Missouri, School of Medicine, Columbia, MO, USA.
Mark S GoldDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.
Keerthy SunderKarma Doctors and Karma TMS, Palm Springs, CA, USA.
Rajendra D BadgaiyanDepartment of Psychiatry, Long School of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA.
Ariel University · ILHealth Awareness (United States) · USTexas Southern University · USThe University of Texas Health Science Center at San Antonio · USThomas Jefferson University Hospital · USUniversity at Buffalo, State University of New York · USUniversity of California, Riverside · USUniversity of Missouri · USWashington University in St. Louis · US

Funding

Dopamine Neurotransmission in AddictionI01CX000479 · VA · VA WESTERN NEW YORK HEALTHCARE SYSTEM · PI BADGAIYAN, RAJENDRA D · 2013 to 2014
–
CSRD VA I01 CX000479
6 · The paper itself

Abstract

It is with a saddened heart that we are dedicating this article to the loving memory of our dear departed friend and associate B. William Downs. Bill was well known in the nutritional space worldwide for his major contributions to the health and welfare of millions around the globe. The founder of Victory Nutrition International (VNI) in conjunction with Kim Downs, as well as so many contributions to scientific literature, to those that knew him personally will forever be touched. Bill was a highly spirited human with a never ending love for caring and helping so many individuals. To know Bill is to walk in the face of a music lover playing drums, trained as a martial artist, and riding through the winds of a Beamer driven by an iconic man driven to victory. Our hearts may be saddened but Bills spirit to those that know him will be forever. In this article we discuss and review some potential futuristic concepts and technological advancements in terms of geneospirituality engineering to help prevent relapse and or even protect against an unwanted predisposition to RDS behaviors. Futuristic development may contribute to an attenuation of both DNA antecedents as well as epigenetic reward system insults leading to unwanted substance and non-substance addictive behaviors.

Indexed as

Futuristic ThinkingGeneospiritualityReward Deficiency Syndrome (RDS)

Identifiers

PMID37361347
PMCPMC10288602
OpenAlexW4382182285

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.